Madrigal Pharmaceuticals | 8-K: Madrigal Pharmaceuticals Reports Fourth-Quarter and Full-Year 2024 Financial Results and Announces New Two-Year Data Demonstrating Potential Benefit of Rezdiffra (resmetirom) in Patients with Compensated MASH Cirrhosis
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Market Insights
Discussing
The tariff deferral period has been extended! How have trade policies in various countries evolved?
Recently, U.S. President Trump announced that the period for "reciprocal tariffs" would be postponed from July 9 to August 1, and declared t
Food流油
Apr 14 15:43
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"